Prognostic Model for Resected Squamous Cell Lung Cancer: External Multicenter Validation and Propensity Score Analysis exploring the Impact of Adjuvant and Neoadjuvant Treatment

A model based on a combination of easily available clinicopathological factors effectively stratifies patients with resected SQLC into three risk classes.